Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation

Bone

Volumn 41, Issue 1, 2007, Pages 87-96

  Shi, Yan chuan ^a   Worton, Leah ^b   Esteban, Luis ^a   Baldock, Paul ^a   Fong, Colette ^a   Eisman, John A ^a   Gardiner, Edith M ^b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

1,25D3; LiCl; MC3T3 E1; Proliferation and differentiation; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; LITHIUM CHLORIDE; OSTEOCALCIN; VITAMIN D; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BONE MASS; BONE MATRIX; BONE TISSUE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; MINERALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN SYNTHESIS;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; CALCITRIOL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN TYPE I; DNA PRIMERS; L CELLS (CELL LINE); LITHIUM CHLORIDE; MICE; OSTEOBLASTS; OSTEOCALCIN; SIGNAL TRANSDUCTION; TRANSFECTION; VITAMIN D; WNT PROTEINS;

EID: 34250205952     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.04.174     Document Type: Article

References (57)

1. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16 (1997) 3797-3804
2. Bain G., Muller T., Wang X., and Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301 (2003) 84-91
3. Beck Jr. G.R., Sullivan E., Moran C., and Zerler E. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 68 (1998) 269-280
4. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280 (1998) 596-599
5. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102 (2005) 3324-3329
6. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18 (2004) 1222-1237
7. Boland G.M., Perkins G., Hall D.J., and Tuan R.S. Wnt3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93 (2004) 1210-1230
8. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346 (2002) 1513-1521
9. Broess M., Riva A., and Gerstenfeld L.C. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. J Cell Biochem 57 (1995) 440-451
10. Candeliere G.A., Rao Y., Floh A., Sandler S.D., and Aubin J.E. cDNA fingerprinting of osteoprogenitor cells to isolate differentiation stage-specific genes. Nucleic Acids Res 27 (1999) 1079-1083
11. Chen T.L., and Fry D. Hormonal regulation of the osteoblastic phenotype expression in neonatal murine calvarial cells. Calcif Tissue Int 64 (1999) 304-309
12. Choi J.Y., Lee B.H., Song K.B., Park R.W., Kim I.S., Sohn K.Y., et al. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J Cell Biochem 61 (1996) 609-618
13. Eelen G., Verlinden L., van Camp M., van Hummelen P., Marchal K., de Moor B., et al. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J Bone Miner Res 19 (2004) 133-146
14. Esteban L.M., Fong C., Amr D., Cock T.A., Allison S.J., Flanagan J.L., et al. Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform. Biochem Biophys Res Commun 334 (2005) 9-15
15. Fretz J.A., Zella L.A., Kim S., Shevde N.K., and Pike J.W. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol Endocrinol 20 (2006) 2215-2230
16. Gardiner E.M., Baldock P.A., Thomas G.P., Sims N.A., Henderson N.K., Hollis B., et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 14 (2000) 1908-1916
17. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523
18. Hedgepeth C.M., Conrad L.J., Zhang J., Huang H., Lee C., and Klein V.M. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185 (1997) 82-91
19. Hendy G.N., Hruska K.A., Mathew S., and Goltzman D. New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int 69 (2006) 218-223
20. Huelsken J., and Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 11 (2001) 547-553
21. Hughes T.A. Regulation of gene expression by alternative untranslated regions. Trends Genet 22 (2006) 119-122
22. Ishida Y., Bellows C.G., Tertinegg I., and Heersche J.N. Progesterone-mediated stimulation of osteoprogenitor proliferation and differentiation in cell populations derived from adult or fetal rat bone tissue depends on the serum component of the culture media. Osteoporos Int 7 (1997) 323-330
23. Jensen S.S., Madsen M.W., Lukas J., Binderup L., and Bartek J. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 15 (2001) 1370-1380
24. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 94 (1997) 9831-9835
25. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70 (2002) 11-19
26. Liu P., Oyajobi B.O., Russell R.G., and Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) in vitro. Calcif Tissue Int 65 (1999) 173-180
27. Matsumoto T., Igarashi C., Takeuchi Y., Harada S., Kikuchi T., Yamato H., et al. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 12 (1991) 27-32
28. Mulholland D.J., Dedhar S., Coetzee G.A., and Nelson C.C. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?. Endocr Rev 26 (2005) 898-915
29. Murray S., Glackin C., and Murray E. Variation in 1,25-dihydroxyvitamin D3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines. J Steroid Biochem Mol Biol 46 (1993) 227-233
30. Nakashima A., Katagiri T., and Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem 280 (2005) 37660-37668
31. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
32. Orford K., Crockett C., Jensen J.P., Weissman A.M., and Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272 (1997) 24735-24738
33. Owen T.A., Bortell R., Yocum S.A., Smock S.L., Zhang M., Abate C., et al. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci 87 (1990) 9990-9994
34. Palmer H.G., Gonzalez-Sancho J.M., Espada J., Berciano M.T., Puig I., Baulida J., et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154 (2001) 369-387
35. Peifer M., and Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287 (2000) 1606-1609
36. Pradeep A., Sharma C., Sathyanarayana P., Albanese C., Fleming J.V., Wang T.C., et al. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene 23 (2004) 3689-3699
37. Rawadi G., Vayssiere B., Dunn F., Baron R., and Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18 (2003) 1842-1853
38. Robinson J.A., Chatterriee-Kishore M., Yaworsky P.J., Cullen D.M., Zhao W., Li C., et al. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Cell Biochem 28 (2006) 31720-31780
39. Sawakami K., Robling A.G., Ai M., Pitner N.D., Liu D., Warden S.J., et al. The WNT co-receptor LRP5 is essential for skeletal mechanotransduction, but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281 (2006) 1842-1853
40. Sciaudone M., Gazzerro E., Priest L., Delany A.M., and Canalis E. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144 (2003) 5631-5639
41. Shah S., Islam M.N., Dakshanamurthy S., Rizvi I., Rao M., Herrell R., et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 21 (2006) 799-809
42. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96 (1999) 5522-5527
43. Shui C., and Scutt A.M. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro. J Cell Physiol 193 (2002) 164-172
44. Sooy K., Sabbagh Y., and Demay M.B. Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro. J Cell Biochem 94 (2005) 81-87
45. St-Arnaud R., Prud'homme J., Leung-Hagesteijn C., and Dedhar S. Constitutive expression of calreticulin in osteoblasts inhibits mineralization. J Cell Biol 131 (1995) 1351-1359
46. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6 (1996) 1664-1668
47. Stein G.S., Lian J.B., and Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4 (1990) 3111-3123
48. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
49. Tobimatsu T., Kaji H., Sowa H., Naito J., Canaff L., Hendy G.N., et al. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147 (2006) 2583-2590
50. van den Bemd G.J., Pols H.A., Birkenhager J.C., Kleinekoort W.M., and van Leeuwen J.P. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption. J Steroid Biochem Mol Biol 55 (1995) 337-346
51. Westendorf J.J., Kahler R.A., and Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 341 (2004) 19-39
52. Whyte M.P. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15 (1994) 439-461
53. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
54. Yamamoto Y., Yoshizawa T., Fukuda T., MNakamura T., Yamada T., Karsenty G., et al. A genetic evidence of direct VDR function in osteoblasts-generation and analysis of osteoblast-specific VDRKO mice. J Bone Miner Res 1099 (2004) [abstract]
55. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16 (1997) 391-396
56. Zamurovic N., Cappellen D., Rohner D., and Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 279 (2004) 37704-37715
57. zur Nieden N.I., Kempka G., and Ahr H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71 (2003) 18-27